Merck & Co. is facing another supply interruption for its ovulation-stimulating hormone Follistim, and like the supply lapse from several years ago, Merck has little to say.
Avnet Inc. has entered into a partnership with Arizona State University and its Ira A. Fulton Schools of Engineering to create the Avnet Innovation Lab.
Technavio analysts are forecasting positive growth for many segments of the global IT spending market by industry over the next four years as several related markets, including IT spending in railways, spending in airports and healthcare supply chain management, will likely witness an increase in revenues.
Executives are likelier than ever to believe that geopolitical and domestic political instability will affect global business and their own companies in coming years, according to the newest McKinsey Global Survey on globalization.
The total cost of ground transportation for Canadian shippers increased by 1.5 percent in March, as compared with February results, according to the most recent Canadian General Freight Index.
Spot truckload freight volume and available capacity both fell during the week ending May 21, according to DAT Solutions, which operates the DAT network of load boards. However, load-to-truck ratios increased and diesel prices have been rising sharply - an indication that spot rates may pick up soon.
The total cost of having a vehicle fleet fell by 14 percent from 2014 to 2015 due primarily lower fuel prices, according to the inaugural Element Fleet Total Cost of Ownership Index.
Anyone managing a supply chain has to have a good head for logistics, coordinating a number of sources in manufacturing or procurement, negotiating for the best supplies at the best prices, and navigating a maze of partners on all levels. This means an extensive amount of time taken for inventory and cataloguing.
More and more drug makers are giving continuous manufacturing a try, seeing it as the future in small molecule drug production, in part, because the plants for the process are much smaller than those for batch processing. Now, scientists at MIT have a prototype of a continuous manufacturing device so small it might be used by pharmacies to produce their own generic drugs.